Adult
Conditions
Interventions
Intake of one Kamaboko (45g) per day for 12 weeks.
Sponsors
Niigata Bio-Research Park, Inc
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Persons whose Fasting blood glucose level is 110 mg/dL or more and less than 126 mg/dL in the results of the pre-test. 2.Persons who are judged by the investigator to be able to safely participate in the study based on the results of the pre-test.
Exclusion criteria
Exclusion criteria: 1.Persons receiving treatment or medication for diabetes. 2.Persons who HbA1c 6.5% or higher. 3.Persons undergoing treatment for gastrointestinal diseases. 4.Persons undergoing treatment for cardiovascular disease. 5.Persons undergoing treatment for psychiatric disorders. 6.Pregnant and lactating women. 7.Persons with a history of allergic reactions to seafood, chicken eggs, wheat, or soybeans. 8.Persons who currently participating in another clinical trial or participated in one within the past 3 months. 9.Other persons deemed ineligible by the study investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Area under the curve of blood glucose level | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose levels, insulin levels, Area under the curve of insulin level | — |
Countries
Japan
Contacts
Public ContactHiroshi Goto
Niigata Bio-Research Park, Inc Business Promotion Department
Outcome results
None listed